Compare MCK & ICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MCK | ICE |
|---|---|---|
| Founded | 1833 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 107.4B | 86.5B |
| IPO Year | N/A | 2005 |
| Metric | MCK | ICE |
|---|---|---|
| Price | $819.05 | $160.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $882.69 | $194.70 |
| AVG Volume (30 Days) | 868.8K | ★ 3.6M |
| Earning Date | 02-04-2026 | 02-05-2026 |
| Dividend Yield | 0.40% | ★ 1.20% |
| EPS Growth | ★ 66.19 | 30.10 |
| EPS | ★ 32.12 | 5.49 |
| Revenue | ★ $387,094,000,000.00 | $9,750,000,000.00 |
| Revenue This Year | $14.87 | $7.73 |
| Revenue Next Year | $8.32 | $5.52 |
| P/E Ratio | ★ $25.54 | $29.20 |
| Revenue Growth | ★ 17.23 | 6.48 |
| 52 Week Low | $565.75 | $142.29 |
| 52 Week High | $895.58 | $189.35 |
| Indicator | MCK | ICE |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 56.12 |
| Support Level | $801.21 | $159.59 |
| Resistance Level | $824.95 | $162.29 |
| Average True Range (ATR) | 16.74 | 2.25 |
| MACD | -2.27 | 0.17 |
| Stochastic Oscillator | 45.20 | 54.69 |
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Intercontinental Exchange is a vertically integrated operator of financial exchanges and provides ancillary data products. Though the company is probably best known for its ownership of the New York Stock Exchange, which it acquired in 2013, ICE operates a large derivatives exchange, too. The company's largest commodity futures product is the ICE Brent crude futures contract. In addition to the exchanges business, which is about 54% of net revenue, Intercontinental Exchange has used a series of acquisitions to create its mortgage technology business (22% of net revenue) and fixed-income and data services segment (24% of net revenue).